Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg
This study has been completed.
Study NCT00826358.
Last updated on January 27, 2009.
Information provided by Abbott
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
